Rheumatology
Conference Coverage
Sustained-release steroid provides prolonged OA pain relief
Key clinical point: A single intra-articular injection of FX006 provided pain relief for up to 12 weeks. Major finding: The mean daily pain...
News
Clazakizumab safe, effective for PsA treatment
Conference Coverage
Persistent knee pain predicts structural osteoarthritis early
Key clinical point: Several signs and symptoms could be used to help identify patients with osteoarthritis (OA) up to 5 years before joint damage...
Conference Coverage
Less symptomatic patients ‘worse off’ after knee surgery
Key clinical point: Patients with milder osteoarthritis can fare worse after knee replacement surgery, and the cost-effectiveness of the procedure...
News
Inflectra becomes first FDA-approved biosimilar for inflammatory diseases
News
Long-term antibiotics ineffective for persistent Lyme disease
Key clinical point: Long-term is no better than standard antibiotic therapy for persistent symptoms of Lyme disease. Major finding: After 14 weeks...
News
Early RA remission more unstable in the presence of foot synovitis
Clinicians should consider escalating therapy in patients with early RA who have persistent foot synovitis regardless of disease activity status,...
News
New gout drug under investigation has dual benefit
Key clinical point: The investigational uricosuric drug arhalofenate significantly reduced the incidence of flares in gout patients and also...
News
Genetics, smoking, and inflammation on MRI predict progression in axial SpA
In patients with early axial spondyloarthritis, progression to structural damage is slow, but those who do progress are more likely to be a...
News
Lupus patients’ transition to adult care leaves gaps, delays in care
Key clinical point: Lupus patients undergoing transition need better education on the importance of prompt follow-up care with adult...